(Q37949284)

25 August 2017

Influenza neuraminidase: a druggable target for natural products (English)

1 reference

25 August 2017

1 reference

5

1 reference

25 August 2017

4

Johannes Kirchmair

0 references

Ulrike Grienke

object named as

Ulrike Grienke

series ordinal

1

0 references

Judith M Rollinger

object named as

Judith M Rollinger

series ordinal

6

0 references

Susanne von Grafenstein

series ordinal

3

object named as

Susanne von Grafenstein

1 reference

25 August 2017

2

Michaela Schmidtke

1 reference

25 August 2017

25 October 2011

1 reference

25 August 2017

Natural Product Reports

1 reference

25 August 2017

29

1 reference

25 August 2017

11-36

1 reference

25 August 2017

1

1 reference

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

25 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Pandemic and seasonal influenza: therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Antivirals for influenza: historical perspectives and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structures of influenza A proteins and insights into antiviral drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Emergence and pandemic potential of swine-origin H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitor resistance in influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The threat of avian influenza A (H5N1). Part III: Antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Natural product-likeness score and its application for prioritization of compound libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Tissue-specific contributions of pneumococcal virulence factors to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structure and functions of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Influenza B virus neuraminidase can synthesize its own inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Virology. The origin and control of pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Influenza virus neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Global transmission of oseltamivir-resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Resistance of influenza viruses to neuraminidase inhibitors--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The evolution of influenza resistance and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structural basis for oseltamivir resistance of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Permissive secondary mutations enable the evolution of influenza oseltamivir resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Crystal structures of respiratory pathogen neuraminidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The Structure of Clostridium perfringens NanI Sialidase and Its Catalytic Intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structure of the catalytic domain ofStreptococcus pneumoniaesialidase NanA

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Crystal structure of the NanB sialidase from Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitors from Reynoutria elliptica

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Expression of a novel human sialidase encoded by the NEU2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Cloning, expression, and chromosomal mapping of a human ganglioside sialidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Limited inhibitory effects of oseltamivir and zanamivir on human sialidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Complexity in influenza virus targeted drug design: interaction with human sialidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Three-dimensional structures of influenza virus neuraminidase-antibody complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

In vitro anti-influenza viral activities of constituents from Caesalpinia sappan

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

New stilbenoid with inhibitory activity on viral neuraminidases from Erythrina addisoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Anti-influenza virus activity of biflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

In vitro anti-influenza viral activities of stilbenoids from the lianas of Gnetum pendulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Antioxidant, anti-inflammatory and anti-influenza properties of components from Chaenomeles speciosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8: study on the mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Anti-influenza agents from plants and traditional Chinese medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Anti-influenza agents from Traditional Chinese Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Tamiflu: the supply problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Strategies for efficient lead structure discovery from natural products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Developing a drug-like natural product library

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

In vitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Emerging antiviral targets for influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Mechanism of 150-cavity formation in influenza neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Emerging methods for ensemble-based virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Top leads for swine influenza A/H1N1 virus revealed by steered molecular dynamics approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Elderberry flavonoids bind to and prevent H1N1 infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Einfluß von 2-Desoxy-2.3-dehydro-N-acetylneuraminsäure auf Myxovirus-Neuraminidasen und die Replikation von Influenza- und Newcastle Disease Virus / Influence of 2-Deoxy-2,3-dehydro-N-acetylneuraminic Acid on Myxovirus-neuraminidases and the Replic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Mangiferin Identified in a Screening Study Guided by Neuraminidase Inhibitory Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00053E

21 January 2018

Identifiers

DOI

10.1039/C1NP00053E

1 reference

25 August 2017

1 reference

PubMed ID

22025274